Hospital Revenue Cycle Management Market To Reach $184.35 Billion By 2030

 The global Hospital Revenue Cycle Management Market size is anticipated to reach USD 184.35 billion by 2030, growing at a CAGR of 12.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. Healthcare providers are increasingly prioritizing financial performance and operational efficiency, leading to a surge in the adoption of advanced revenue cycle management (RCM) solutions within hospitals. These solutions are designed to effectively navigate billing complexities, guarantee precise reimbursements, and leverage artificial intelligence, automation, and cloud computing to optimize workflows and improve patient care. This trend is expected to drive the expansion of the hospital revenue cycle market during the forecast period.

The market for hospital revenue cycle management is expected to experience significant growth due to the shift towards value-based care. This shift, which focuses on improving patient outcomes and reducing costs, is driving healthcare providers to invest in robust RCM solutions. As providers focus on aligning financial incentives with patient outcomes, the demand for advanced RCM systems that support value-based care initiatives is increasing. This trend is fueling innovation and adoption in the RCM market, creating opportunities for growth and development.

Key participants are engaged in different strategies to expand their global footprint through innovations, partnership collaborations, and product launches. For instance, in July 2023, State of Franklin Healthcare Associates (SOFHA), a physician-owned multispecialty and primary care healthcare system in Southwest Virginia and upper East Tennessee, extended its partnership with Veradigm LLC by signing a 2-year agreement to use Veradigm Revenue Cycle Services.

List of Key Players in the Hospital Revenue Cycle Management Market

• Athenahealth, Inc.
• CareCloud Corporation
• Epic Systems Corporation
• Evident
• NXGN Management, LLC
• OncoSpark, Inc.
• Oracle
• R1 RCM, Inc.
• The SSI Group, LLC
• Veradigm LLC

Request a free sample copy or view report summary: Hospital Revenue Cycle Management Market Report

Hospital Revenue Cycle Management Market Report Highlights:

• Based on product, the services segment dominated the market with largest revenue share in 2023. This is attributed to the rise in outsourcing services offered to hospitals by a growing number of companies. Additionally, established market players are contributing to this growth through undertaking various strategic initiatives.
• Based on type, the integrated segment dominated the market in 2023 owing to the growing demand among healthcare providers to improve operational efficiency, lower administrative costs, and enhance patient satisfaction.
• Based on delivery mode, the web-based segment dominated the market with a in 2023, owing to an increasing need for scalable and cost-effective solutions that provide real-time access to financial data and streamline billing processes, with web-based RCM systems.
• North America region held the largest market share in 2023. This is attributed to the rising healthcare expenses, expanding government initiatives aimed at RCM system implementation, and the rising adoption of healthcare information technology (HIT) systems.

Hospital Revenue Cycle Management Market Segmentation

Grand View Research has segmented the global hospital revenue cycle management market based on product, type, delivery mode, and region:

Hospital Revenue Cycle Management Product Outlook (Revenue, USD Million, 2018 - 2030)

• Software
• Services

Hospital Revenue Cycle Management Type Outlook (Revenue, USD Million, 2018 - 2030)

• Integrated
• Standalone

Hospital Revenue Cycle Management Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• On-Premises
• Web-Based
• Cloud-Based

Hospital Revenue Cycle Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Hearing Loss Disease Treatment Market To Reach $19.36 Billion By 2030

 

The global Hearing Loss Disease Treatment Market size is expected to reach USD 19.36 billion by 2030, registering a CAGR of 5.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world’s population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals’ Ebselen and Sensorion’s SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere’s Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics’ phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

List of Key Players of Hearing Loss Disease Treatment Market

• Novartis AG
• Acousia Therapeutics GmbH
• Otonomy, Inc.
• Sensorion
• Frequency Therapeutics
• Audifon GmbH & Co. KG
• Pipeline Therapeutics
• Audina Hearing Instruments, Inc.
• Astellas Pharma, Inc.
• WS Audiology A/S

Request a free sample copy or view report summary: Hearing Loss Disease Treatment Market Report

Hearing Loss Disease Treatment Market Report Highlights

• The devices segment dominated the industry in 2023 and accounted for the maximum share of more than 90.65% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
• The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
• The sensorineural hearing loss segment dominated the industry in 2023 and accounted for the maximum share of more than 57.04% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
• The otology clinics end-user segment, in 2023, accounted for the second-highest share of 45.18% of the overall revenue.
• Asia Pacific is expected to be the fastest-growing region from 2024 to 2030 due to the rising number of target patients and funding support to major players in the region.

Hearing Loss Disease Treatment Market Segmentation

Grand View Research has segmented the global hearing loss disease treatment market report on the basis of product, disease type, end-user, and region:

Hearing Loss Disease Treatment Product Outlook (Revenue, USD Million, 2018 - 2030)

• Devices
• Drugs
• Systemic steroids
• Antiviral medication
• Vasodilators
• Others

Hearing Loss Disease Treatment Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

• Conductive Hearing Loss
• Sensorineural Hearing Loss
• Mixed (Conductive and Sensorineural)

Hearing Loss Disease Treatment End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Otology clinics
• Ambulatory clinics

Hearing Loss Disease Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

California Legal Cannabis Market: Industry Demand, Analysis And Future Trends 2030

 The California Legal Cannabis Market size is projected to reach USD 10.34 billion by 2030, expanding at a CAGR of 9.4% during the forecast period, according to a report by Grand View Research, Inc.  The growth is driven by rising awareness regarding the benefits associated with the use of cannabis products for post-traumatic stress disorder (PTSD) and Alzheimer’s. According to a study conducted by National Alliance on Mental Illness California found that around 9 million adults in the U.S. are affected by PTSD.

Moreover, according to Alzheimer’s Association, around 690,000 adults aged more than 65 years are suffering from Alzheimer’s and more than 7% of adults aged 45 years and above are suffering from subjective cognitive decline in the state. Additionally, according to a study published by NCBI in 2022, the adoption of cannabis for the treatment of mental health disorders such as PTSD is increasing among citizens in the U.S.

The rising government efforts in the form of funding and initiatives are driving the demand for the market in the state. For instance, in April 2023, the California Department of Cannabis Control (DCC) announced funding of USD 20 million for the scientific study on the effect of cannabis derivatives, such as Delta-10 THC and Delta-8, on the mental health of the young population. Moreover, the governor of California signed 10 marijuana-related bills in September 2022. These bills are expected to facilitate interstate commerce of cannabis and offer employment protections for marijuana customers. The aforementioned factors are anticipated to fuel the market growth over the forecast period.

California legalized cannabis for medical use in 1996 by passing the Compassionate Use Act with 55.6% votes. The law offered legal protection to caregivers, physicians, and patients against marijuana possession and use. Proposition 64 was passed in 2016, which legalized the recreational use of cannabis. Under this law, an adult aged 21 years and older can possess 28 grams of concentrated cannabis and can cultivate six plants per residence.

The presence of key players, such as Punch Edibles Media, LLC, Leef, Jetty Extracts, Agrowth, 4C Labs, Catalyst Cannabis Co., Harborside, and THC Design, is positively impacting the market. Major operators are adopting strategies such as partnerships, expansions, acquisitions, new product launches, and collaboration to strengthen their market position. For instance, in January 2023, Jetty Extracts, a high-grade cannabis extracts producer in California, announced its expansion in New York by entering into partnerships with retailers and local producers. Moreover, in April 2022, Harborside Inc. announced the acquisition of LPF JV Corporation, a manufacturer, cultivator, and distributor of cannabis brands in the state. This strategic acquisition is anticipated to expand the company’s market share significantly.

Request a free sample copy or view report summary: California Legal Cannabis Market Report

California Legal Cannabis Market Segmentation

Grand View Research, Inc. has segmented the California legal cannabis market based on source, product, cultivation end-use:

California Legal Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)

• Hemp
• Hemp CBD
• Industrial Hemp
• Marijuana
• Flower
• Oil and Tinctures

California Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2018 - 2030)

• CBD
• THC
• Others

California Legal Cannabis Cultivation Outlook (Revenue, USD Million, 2018 - 2030)

• Indoor Cultivation
• Greenhouse Cultivation
• Outdoor Cultivation

California Legal Cannabis End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Industrial Use
• Medical Use
• Chronic Pain
• Depression and Anxiety
• Arthritis
• Post-traumatic Stress Disorder (PTSD)
• Cancer
• Migraines
• Epilepsy
• Alzheimer’s
• Multiple Sclerosis
• AIDS
• Amyotrophic Lateral Sclerosis
• Tourette’s
• Diabetes
• Parkinson's
• Glaucoma
• Others
• Recreational Use

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Healthcare Fraud Analytics Market Share, Growth and Future Analysis

 

The global Healthcare Fraud Analytics Market size is expected to reach USD 11.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to advance at a CAGR of 24.3% from 2022 to 2030. The rising incidence of fraudulent activities in the healthcare sector, increasing number of patients seeking health insurance, high returns on investment, and the increasing number of pharmacy claims-related frauds are the major drivers propelling the market growth.

The COVID-19 pandemic has drastically affected the healthcare industry. The healthcare industry has observed various fraud cases on the part of doctors, patients, physicians, and other healthcare specialists. It is observed that many medical specialists and healthcare providers are engaged in fraudulent activities for profit gains. Many instances prove the increasing number of fraud cases during the COVID-19 pandemic.

The adoption of software used for fraud detection by insurance companies is increasing due to the rising availability of the same in developed regions. For instance, in February 2022, The Canadian Life and Health Insurance Association (CLHIA) launched an industry initiative to pool claims data and use advanced artificial intelligence tools which enhance the investigation and detection of benefits fraud.

Moreover, in June 2021, Artivatic launched the Alfred- AI Health Claims platform. This platform automates end-to-end health claims, and the abuse & fraud detection capacity is almost 30% or more. Moreover, it enables users to self-learn and develop a system for decision-making, risk assessment, and fraud detection. This growth in the availability of the software is because of increasing healthcare expenditure, which triggers the companies to come up with a product or service to meet the market demand.

The rising incidence of fraudulent activities in the healthcare sector drives the market globally. For example, according to data published by the National Library of Medicine, the fraudulent activities count raised from 30 in 2019 to 52 in the year 2021. The market is highly competitive and consists of several major players. With the rising adoption of healthcare IT solutions and the increasing number of fraud cases, smaller or private players are anticipated to enter the market in the coming years.

Initiatives like collaborations or partnerships with local players, acquisitions, or new product launches by market players contribute to the market growth. For example, in April 2019, HCL Technologies Limited launched the CyberSecurity Fusion Center in Texas, U.S., and expanded its U.S. operations with the CyberSecurity Center.

List of Key Players in the Healthcare Fraud Analytics Market

• IBM
• Optum, Inc.
• Cotiviti, Inc
• DXC Technology
• SAS Institute, Inc.
• EXL Service Holdings, Inc
• Wipro Limited
• Conduent, Inc
• HCL Technologies Limited
• OSP Labs

Request a free sample copy or view the report summary: Healthcare Fraud Analytics Market Report

Healthcare Fraud Analytics Market Report Highlights

• In terms of revenue, the descriptive analytics segment dominated the solution type segment with a share of around 40.5% in 2021, owing to its high penetration
• Based on the delivery model, the on-premise segment is expected to show lucrative growth during the forecast period, owing to its higher deployment as compared to the cloud-based delivery model
• Insurance claims review dominated the application segment with a share of around 35% as of 2021. The growth can be attributed to the rising adoption of health insurance
• The employers' segment is expected to show the fastest growth during the forecast period, owing to the increasing demand for healthcare fraud analytics software by employers for better cost management
• The North American region accounted for the largest market share of around 38% in 2021, owing to the presence of major market players in the region 

Healthcare Fraud Analytics Market Segmentation

Grand View Research has segmented the global healthcare fraud analytics market based on solution type, application, delivery model, end-user, and region:

Solution Type Outlook (Revenue, USD Million, 2017 - 2030)

• Descriptive Analytics
• Predictive Analytics
• Prescriptive Analytics

Delivery Model Outlook (Revenue, USD Million, 2017 - 2030)

• On-premise
• Cloud-based

Application Type Outlook (Revenue, USD Million, 2017 - 2030)

• Insurance Claim Review
• Postpayment Review
• Prepayment Review
• Pharmacy Billing Issue
• Payment Integrity
• Others

End-User Outlook (Revenue, USD Million, 2017 - 2030)

• Public & Government Agencies
• Private Insurance Payers
• Third-party Service Providers
• Employers

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com